Perceptual and physiologic responses during treadmill and cycle exercise in patients with COPD

Chest

Volumn 135, Issue 2, 2009, Pages 384-390

  Murray, James A ^a   Waterman, Laurie A ^b   Ward, Joseph ^b   Baird, John C ^d   Mahler, Donald A ^b,c  

^a UNITY HEALTH SYSTEM   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d Psychological Applications   (United States)

Author keywords

Continuous ratings of breathlessness; Continuous ratings of leg discomfort; COPD; Cycle ergometry; Treadmill exercise

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; SALBUTAMOL; THEOPHYLLINE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLING; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEG DISCOMFORT; LEG DISEASE; LUNG MINUTE VOLUME; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TREADMILL EXERCISE;

EID: 60249096836     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1258     Document Type: Article

References (32)

1. Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2005; 80-83
2. American Thoracic Society and American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167:211-277
3. ERS Task Force on Standardization of Clinical Exercise Testing. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. Eur Respir J 1997; 10:2662-2689
4. Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146:935-940
5. Man WD, Soliman MG, Gearing J, et al. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168:562-567
6. Palange P, Forte S, Onorati P, et al. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J Appl Physiol 2000; 88:1715-1720
7. Pepin V, Saey D, Whittom F, et al. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:1517-1522
8. Brouillard C, Pepin V, Milot J, et al. Endurance shuttle walking test: responsiveness to salmeterol in COPD. Eur Respir J 2008; 31:579-584
9. Mahler DA. Measurement of dyspnea ratings during exercise. In: Mahler DA, O'Donnell DE, eds. Dyspnea: mechanisms, measurement, and management. 2nd ed. Boca Raton, FL: Taylor & Frances, 2005; 167-182
10. Mahler DA, Fierro-Carrion G, Baird JC. Mechanisms and measurement of exertional dyspnea. In: Weisman IM, Zeballos RJ, eds. Clinical exercise testing: progress in respiratory research. Basel, Switzerland: Karger, 2002; 72-80
11. Murray JA, Waterman L, Ward J, et al. Continuous reporting of breathlessness during exercise in patients with chronic obstructive pulmonary disease: a comparison of exercise on the cycle ergometer vs. treadmill. [abstract]. Am J Respir Crit Care Med 2007; 175:A367
12. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946
13. Mahler DA, Ward J, Fierro-Carrion G, et al. Development of self-administered versions of the modified baseline and transition dyspnea indexes in COPD. J COPD 2004; 1:165-172
14. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123:659-664
15. Gaensler EA, Smith AA. Attachment for automated single breath diffusing capacity measurement. Chest 1973; 63:136-145
16. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14:377-381
17. Mahler DA, Mejia-Alfaro R, Ward J, et al. Continuous measurement of breathlessness during exercise: validity, reliability, and responsiveness. J Appl Physiol 2001; 90:2188-2196
18. Harty HR, Heywood P, Adams L. Comparison between continuous and discrete measurements of breathlessness during exercise in normal subjects using a visual analogue scale. Clin Sci (Lond) 1993; 85:229-236
19. O'Donnell DE, Bertley JC, Chau LK, et al. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155:109-115
20. Fierro-Carrion G, Mahler DA, Ward J, et al. Comparison of continuous and discrete measurements of dyspnea during exercise in patients with COPD and normal subjects. Chest 2004; 125:77-84
21. Baird JC. Sensory psychophysics. In: Kotses H, Harver A, eds. Self-management of asthma. New York: NY: Marcel Dekker, 1998; 231-267
22. Baird JC, Noma E. Fundamentals of scaling and psychophysics. New York, NY: Wiley Interscience, 1978; 1-65
23. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:1557-1565
24. Mahler DA, Waterman LA, Ward J, et al. Responsiveness of patient-reported breathlessness during exercise in persistent asthma. Chest 2007; 131:195-200
25. Oga T, Nishimura K, Tsukino M, et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease: a comparison of three different exercise tests. Am J Respir Crit Care Med 2000; 161:1897-1901
26. Mahler DA, Fierro-Carrion G, Mejia-Alfaro R, et al. Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD. Med Sci Sports Exerc 2005; 37:529-535
27. Mathur RS, Revill SM, Vara DD, et al. Comparison of peak oxygen consumption during cycle and treadmill exercise in severe chronic obstructive pulmonary disease. Thorax 1995; 50:829-833
28. O'Donnell DE, Sciurba F, Celli B, et al. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006; 130:647-656
29. O'Donnell DE, Voduc N, Fitzpatrick M, et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24:86-94
30. Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005; 128:1168-1178
31. O'Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23:832-840
32. Morgan MD, Singh SJ. Assessing the exercise response to a bronchodilator in COPD: time to get off your bike? Thorax 2007; 62:281-283